Clinical Trial Update: A Trial Investigating the Effect of NN5401 in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating NN5401 in subjects with Type 2 diabetes has been completed. The study was sponsored by Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NN5401

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED